Harold J. Burstein/X
Dec 15, 2024, 19:48
Harold J Burstein: Important presentation on anthracyclines and outcomes in TAILORx
Harold J Burstein, Breast Cancer Specialist and Professor at Harvard Medical School, shared on X:
“Important presentation on anthracyclines and outcomes in TAILORx by OncotypeDX score.
Anthracycline chemo benefit over TC limited to T2 or larger tumors with ODX => 31.
See also our recent JCO ASCO editorial on this topic.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 23, 2025, 10:34
Feb 23, 2025, 10:29
Feb 23, 2025, 10:27
Feb 23, 2025, 10:24
Feb 23, 2025, 10:13
Feb 23, 2025, 10:11
Feb 23, 2025, 10:08
Feb 23, 2025, 10:03
Feb 23, 2025, 09:45